ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2463
0,00%
Bitcoin
67.394,63
-0,49%
Brent Oil
81,295
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. eFFECTOR Therapeutics Inc (EFTR)

  7. eFFECTOR Therapeutics Inc (EFTR) Notícias

EFTR

eFFECTOR Therapeutics (EFTR)

eFFECTOR Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EFTR
DataHoraFonteTítuloCódigoCompanhia
21/02/202419:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EFTReFFECTOR Therapeutics Inc
09/02/202422:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EFTReFFECTOR Therapeutics Inc
30/01/202410:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EFTReFFECTOR Therapeutics Inc
26/01/202418:32Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EFTReFFECTOR Therapeutics Inc
10/01/202410:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EFTReFFECTOR Therapeutics Inc
13/11/202318:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EFTReFFECTOR Therapeutics Inc
27/06/202307:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EFTReFFECTOR Therapeutics Inc
23/06/202317:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202307:15Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/06/202307:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:EFTReFFECTOR Therapeutics Inc
16/05/202309:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EFTReFFECTOR Therapeutics Inc
12/05/202317:24Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:EFTReFFECTOR Therapeutics Inc
12/05/202317:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EFTReFFECTOR Therapeutics Inc
12/05/202317:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EFTReFFECTOR Therapeutics Inc
09/05/202317:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EFTReFFECTOR Therapeutics Inc
08/03/202318:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EFTReFFECTOR Therapeutics Inc
07/03/202319:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:EFTReFFECTOR Therapeutics Inc
14/02/202308:35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EFTReFFECTOR Therapeutics Inc
17/11/202202:41TipRanksAnalysts’ Top Healthcare Picks: CureVac (CVAC), eFFECTOR Therapeutics (EFTR)NASDAQ:EFTReFFECTOR Therapeutics Inc
07/11/202219:35TipRanksMizuho Securities Reaffirms Their Buy Rating on eFFECTOR Therapeutics (EFTR)NASDAQ:EFTReFFECTOR Therapeutics Inc
28/09/202217:43Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EFTReFFECTOR Therapeutics Inc
14/09/202212:45TipRanksMizuho Securities Keeps Their Buy Rating on eFFECTOR Therapeutics (EFTR)NASDAQ:EFTReFFECTOR Therapeutics Inc
11/08/202217:56Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EFTReFFECTOR Therapeutics Inc
11/08/202201:15TipRanksJMP Securities Sticks to Their Buy Rating for eFFECTOR Therapeutics (EFTR)NASDAQ:EFTReFFECTOR Therapeutics Inc
09/08/202221:25TipRanksMizuho Securities Sticks to Its Buy Rating for eFFECTOR Therapeutics (EFTR)NASDAQ:EFTReFFECTOR Therapeutics Inc
09/08/202217:01GlobeNewswire Inc.eFFECTOR Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:EFTReFFECTOR Therapeutics Inc
08/08/202206:30GlobeNewswire Inc.eFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical OfficerNASDAQ:EFTReFFECTOR Therapeutics Inc
07/06/202209:00GlobeNewswire Inc.eFFECTOR Therapeutics to Present at JMP Securities Life Sciences ConferenceNASDAQ:EFTReFFECTOR Therapeutics Inc
06/06/202201:45TipRanksJMP Securities Thinks eFFECTOR Therapeutics’ Stock is Going to RecoverNASDAQ:EFTReFFECTOR Therapeutics Inc
05/06/202218:00GlobeNewswire Inc.eFFECTOR Therapeutics Reports Positive Interim Results in Zotatifin (eFT226) Phase 1/2 Clinical Trial at ASCO 2022 Showing Safety and Tolerability, and Initial Signals of Clinical ActivityNASDAQ:EFTReFFECTOR Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:EFTR

Seu Histórico Recente

COIN
BCHBTC
Bitcoin Cash
BOV
VALE3
VALE ON
BOV
ITSA4
ITAUSA PN
NYSE
RIO
Rio Tinto
BOV
B3SA3
B3 SA - Brasil Bolsa Bal... ON
COIN
XRPBTC
Ripple
BOV
PETR4
PETROBRAS PN
COIN
BRAZBTC
Brazio
COIN
BTCUSD
Bitcoin
BOV
GGBR4
GERDAU PN
COIN
ADABTC
Cardano
BOV
BBDC4
BRADESCO PN
BOV
BBAS3
BANCO DO BRASIL ON
COIN
PLUS1BTC
PlusOneCoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados